Stun Medical
Lipo Shrinker
Brand
Stun Medical
Category
Lipolysis
Origin
Korea
Interested in ordering Lipo Shrinker? Send an enquiry and our team will follow up with availability and pricing.
Used in
Overview
Lipo Shrinker is a Korean fat-decomposition injectable distributed by Mirpharma and attributed to Stun Medical, formulated for localised fat reduction with claimed skin-texture and elasticity benefits. It is marketed to target fat within adipocytes to reduce fat-cell size and cellulite appearance. Supplied in 5.5 ml vials (5 vials per box).
How it works
As an injection-lipolysis product, Lipo Shrinker acts on subcutaneous adipocytes to break down stored fat and reduce fat-cell size; the fat-dissolving action in this product class is driven by a bile-acid pathway (deoxycholic acid) that disrupts fat-cell membranes. Released lipids are subsequently mobilised and cleared through the lymphatic and vascular circulation. The manufacturer also claims skin-plumping and cellulite-reduction effects alongside fat breakdown.
Indications
- Submental fat / double chin
- Waist and flanks
- Thighs
- Localised body fat deposits
- Cellulite appearance
Key features
- Fat-decomposition injectable for localised deposits
- Marketed for cellulite reduction and skin plumping
- Deoxycholic-acid-class lipolysis positioning
- 5.5 ml vials, 5 per box
- Simple single-solution treatment workflow
Benefits
- Straightforward single-product protocol for clinic use
- Dual fat-reduction and skin-texture marketing narrative
- Convenient multi-vial packaging for inventory
- Applicable to common face and body fat indications
- Non-surgical, low-downtime treatment offering
Composition
Full active composition is not disclosed on the manufacturer's product page; the product is presented as a fat-decomposition injection within the deoxycholic-acid class of lipolytics. Specific actives and concentrations are not publicly stated.
Usage & handling
For clinician use only. Inject subcutaneously into the target fat pad across a distributed grid using conservative per-point volumes, remaining within the fat layer. Localised swelling, tenderness and bruising are expected and should be counselled in advance. Stage treatment across multiple sessions rather than over-treating in one visit. Maintain awareness of regional nerve and vascular anatomy, particularly around the submental region and jawline.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.